Intuitive Surgical, Inc.

“Intuitive Surgical is an exceptional compounder — fortress balance sheet with zero debt, $2.5B in annual FCF, a 9,500+ unit installed base with irreplaceable clinical evidence, and a decade-plus reinvestment runway at 25%+ ROIC. The risk of permanent capital impairment is genuinely low. The problem is price: at $437 and 53x trailing earnings, the expected 10-year return compresses to roughly 2–3x, or mid-single-digit annualized — insufficient compensation for the volatility and multiple risk embedded in a 1.51-beta, 37x-forward-P/E position. This is a TRACK, not a BUY: the business deserves a permanent place on every serious investor's watchlist, with accumulation triggered on a pullback to the low-$370s where return expectations become more attractive.”